Clinical Trial Update: Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects [Phase 1]

View source ↗

Summary

Phase 1 study of velusetrag in healthy elderly subjects assessing safety, pharmacokinetics and pharmacodynamics; Alzheimer's disease is listed as the condition …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Velusetrag (Velusetrag)

Snippet

Sponsor: Alfasigma S.p.A. | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED